-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kyntra Bio: Phase 2 Monotherapy Trial of FG-3246 Actively Enrolling and Remains on Track for Interim Analysis in 2H

Dow Jones·03/16/2026 20:22:00

Please log in to view news